在神经代谢条件下手术治疗运动障碍
Alonso Zea Vera1,2, Andrea L Gropman2,3
1Division of Neurology, Children's National Hospital, Washington, DC, United States.
Frontiers in neurology
|June 19, 2023
概括
像深度大脑刺激 (DBS) 这样的外科干预方法可以治疗先天性代谢错误 (IEMs) 的运动障碍. 虽然对像潘托酸激酶相关的神经退行症这样的疾病有希望,但需要进一步的研究来优化患者选择和结果.
科学领域:
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
- 神经外科 神经外科
背景情况:
- 耐火运动障碍,包括 dystonia 和状态 dystonicus,在代谢的先天性错误 (IEMs) 中很普遍.
- 这些运动障碍显著损害生活质量,并可能导致严重的并发症.
- 目前对IEM运动障碍手术干预的理解有限,这给患者管理带来了挑战.
研究的目的:
- 审查现有的关于治疗IEM患者运动障碍的手术技术的文献.
- 评估深度大脑刺激 (DBS) 和神经代谢条件下的损伤技术的有效性和应用.
- 确定未来研究领域,以改善这些患者的外科护理.
主要方法:
- 对IEM中运动障碍的手术治疗发表文献的系统审查.
- 分析病例报告和详细介绍使用DBS和损伤程序的研究.
- 专注于特定的IEMs,如泛氨酸激酶相关的神经退行症和莱什-尼汉病.
主要成果:
- 全球内DBS显示在松酸激酶相关的神经退行症中对 dystonia 有好处.
- 帕利达刺激改善了自我伤害行为,并且在较小程度上改善了莱什-尼汉病的 dystonia.
- 其他IEM研究中的有限样本大小限制了最终的结论,尽管DBS通常优先于损伤技术.
结论:
- 手术干预,特别是DBS,是管理选择IEMs中耐火运动障碍的可行选择.
- 需要对更大的队列进行进一步的研究,以完善外科候选人选择和治疗方案.
- 这一领域的先进知识可以显著提高神经代谢疾病患者的临床护理和治疗结果.
关键词:
深度大脑刺激 刺激大脑迪斯托尼亚 (Dystonia) 是一种精神疾病.运动障碍 运动障碍神经代谢障碍是一种神经代谢障碍.这是一次帕利多托米 (pallidotomy).这是一种thalamotomy.更多相关视频
相关概念视频
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Psychosurgery
81
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
81
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Skeletal Muscle Relaxants: Therapeutic Uses
521
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
521


